Zobrazeno 1 - 10
of 335
pro vyhledávání: '"Raaphorst J."'
Autor:
Saygin, D, DiRenzo, D, Raaphorst, J, de Groot, I, Bingham, CO, Lundberg, IE, Regardt, M, Sarver, C, de Visser, M, Maxwell, LJ, Beaton, D, Kim, JY, Needham, M, Alexanderson, H, Christopher-Stine, L, Mecoli, CA, Park, JK
Publikováno v:
In Seminars in Arthritis and Rheumatism February 2024 64
Autor:
Wieske, L., Stalman, E.W., Dam, P.J.K. van, Kummer, L.Y., Steenhuis, M., Kempen, Z.L.E. van, Killestein, J., Volkers, A.G., Tas, S.W., Boekel, L., Wolbink, G., Kooi, A. van der, Raaphorst, J., Lowenberg, M., Takkenberg, B., D'Haens, G.R.A.M., Spuls, P.I., Bekkenk, M.W., Musters, A.H., Post, N.F., Bosma, A.L., Hilhorst, M.L., Vegting, Y., Bemelman, F.J., Voskuyl, A., Broens, B., Sanchez, A.P., Els, C.A.C.M. van, Wit, J. de, Rutgers, A., Leeuw, K. de, Horvath, B., Verschuuren, J.J.G.M., Ruiter, A.M., Ouwerkerk, L. van, Woude, D. van der, Allaart, C.F., Teng, Y.K.O., Paassen, P. van, Busch, M.H., Jallah, P.B.P., Brusse, E., Doorn, P.A. van, Baars, A.E., Hijnen, D., Schreurs, C.R.G., Pol, W.L. van der, Goedee, H.S., Keijzer, S., Keijser, J., Cristianawati, O., Brinke, A. ten, Verstegen, N.J.M., Zwinderman, K.A.H., Ham, S.M. van, Kuijpers, T.W., Rispens, T., Eftimov, F., T2B Immunity SARS CoV 2 Study Grp
Publikováno v:
Annals of the Rheumatic Diseases, 82(6). BMJ PUBLISHING GROUP
Annals of the Rheumatic Diseases. BMJ Publishing Group
Annals of the Rheumatic Diseases, 82(6):ard-2022-223464, 883-885. BMJ Publishing Group
Wieske, L, Stalman, E W, van Dam, P J K, Kummer, L Y, Steenhuis, M, van Kempen, Z L E, Killestein, J, Volkers, A G, Tas, S W, Boekel, L, Wolbink, G, van der Kooi, A, Raaphorst, J, Löwenberg, M, Takkenberg, B, D'Haens, G R A M, Spuls, P I, Bekkenk, M W, Musters, A H, Post, N F, Bosma, A L, Hilhorst, M L, Vegting, Y, Bemelman, F J, Voskuyl, A, Broens, B, Parra Sanchez, A, van Els, C C A C M, Wit, J D, Rutgers, A, de Leeuw, K, Horváth, B, Verschuuren, J J G M, Ruiter, A M, van Ouwerkerk, L, van der Woude, D, Allaart, C F, Teng, Y K O, van Paassen, P, Busch, M H, Jallah, P B P, Brusse, E, van Doorn, P A, Baars, A E, Hijnen, D, Schreurs, C R G, van der Pol, W L, Goedee, H S, Keijzer, S, Keijser, J, Cristianawati, O, ten Brinke, A, Verstegen, N J M, Zwinderman, K A H, van Ham, S M, Kuijpers, T W, Rispens, T & Eftimov, F 2023, ' Persistence of seroconversion at 6 months following primary immunisation in patients with immune-mediated inflammatory diseases ', Annals of the Rheumatic Diseases, vol. 82, no. 6, ard-2022-223464, pp. 883-885 . https://doi.org/10.1136/ard-2022-223464
Annals of the Rheumatic Diseases. BMJ Publishing Group
Annals of the Rheumatic Diseases, 82(6):ard-2022-223464, 883-885. BMJ Publishing Group
Wieske, L, Stalman, E W, van Dam, P J K, Kummer, L Y, Steenhuis, M, van Kempen, Z L E, Killestein, J, Volkers, A G, Tas, S W, Boekel, L, Wolbink, G, van der Kooi, A, Raaphorst, J, Löwenberg, M, Takkenberg, B, D'Haens, G R A M, Spuls, P I, Bekkenk, M W, Musters, A H, Post, N F, Bosma, A L, Hilhorst, M L, Vegting, Y, Bemelman, F J, Voskuyl, A, Broens, B, Parra Sanchez, A, van Els, C C A C M, Wit, J D, Rutgers, A, de Leeuw, K, Horváth, B, Verschuuren, J J G M, Ruiter, A M, van Ouwerkerk, L, van der Woude, D, Allaart, C F, Teng, Y K O, van Paassen, P, Busch, M H, Jallah, P B P, Brusse, E, van Doorn, P A, Baars, A E, Hijnen, D, Schreurs, C R G, van der Pol, W L, Goedee, H S, Keijzer, S, Keijser, J, Cristianawati, O, ten Brinke, A, Verstegen, N J M, Zwinderman, K A H, van Ham, S M, Kuijpers, T W, Rispens, T & Eftimov, F 2023, ' Persistence of seroconversion at 6 months following primary immunisation in patients with immune-mediated inflammatory diseases ', Annals of the Rheumatic Diseases, vol. 82, no. 6, ard-2022-223464, pp. 883-885 . https://doi.org/10.1136/ard-2022-223464
Patients with immune-mediated inflammatory diseases (IMIDs) may have impaired initial humoral responses after SARS-CoV-2 vaccination depending on the type of immunosuppression (ISP) used.1 It is largely unknown how antibody titres develop over time a
Autor:
Dam, K.P.J. van, Volkers, A.G., Wieske, L., Stalman, E.W., Kummer, L.Y.L., Kempen, Z.L.E. van, Killestein, J., Tas, S.W., Boekel, L., Wolbink, G.J., Kooi, A.J. van der, Raaphorst, J., Takkenberg, R.B., D'Haens, G.R.A.M.I., Spuls, P.W., Bekkenk, M.H., Musters, A.F., Post, N.L., Bosma, A.L., Hilhorst, M., Vegting, Y.J., Bemelman, F.E., Voskuyl, A., Broens, B., Sanchez, A.P., Els, C.A.C.M. van, Wit, J. de, Rutgers, A., Leeuw, K. de, Horvath, B., Verschuuren, J.J.G.M.M., Ruiter, A.M., Ouwerkerk, L. van, Woude, D. van der, Allaart, R.C.F., Teng, Y.K.O., Paassen, P.H. van, Busch, M.H., Jallah, P.B.P., Brusse, E., Doorn, P.A. van, Baars, A.E., Hijnen, D.J., Schreurs, C.R.G., Pol, W.L. van der, Goedee, H.S., Steenhuis, M., Keijzer, S., Keijser, J.B.D., Cristianawati, O., Brinke, A. ten, Verstegen, N.J.M., Ham, S.M. van, Rispens, T.W., Kuijpers, T., Lowenberg, M., Eftimov, F., TB2 Immunity Sars-Cov-2 Study Grp
Background: Patients with immune-mediated inflammatory diseases (IMIDs) on immunosuppressants (ISPs) may have impaired long-term humoral immune responses and increased disease activity after SARS-CoV-2 infection. We aimed to investigate long-term hum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::48e652b90d3e035b57aa8ad553b7a0eb
https://hdl.handle.net/1887/3630357
https://hdl.handle.net/1887/3630357
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Volkov, M., Coppola, M., Huizinga, R., Eftimov, F., Huizinga, T.W.J., Kooi, A.J. van der, Oosten, L.E.M., Raaphorst, J., Rispens, T., Sciarrillo, R., Titulaer, M.J., Wieske, L., Toes, R.E.M., Huijbers, M.G.M., Schie, K.A. van, Woude, D. van der, T2B Consortium
Publikováno v:
T2B Consortium 2022, ' Comprehensive overview of autoantibody isotype and subclass distribution ', Journal of Allergy and Clinical Immunology, vol. 150, no. 5, pp. 999-1010 . https://doi.org/10.1016/j.jaci.2022.05.023
Journal of Allergy and Clinical Immunology, 150(5), 999-1010. MOSBY-ELSEVIER
Journal of Allergy and Clinical Immunology, 150(5), 999-1010. MOSBY-ELSEVIER
The presence of autoreactive antibodies is a hallmark of many autoimmune diseases. The effector functions of (auto)antibodies are determined by their constant domain, which defines the antibody isotype and subclass. The most prevalent isotype in seru
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59192b959ff488b389e565b96a42d84b
https://hdl.handle.net/1887/3512518
https://hdl.handle.net/1887/3512518
Autor:
Stalman, E.W., Wieske, L., Dam, K.P.J. van, Kummer, L.Y., Kempen, Z.L.E. van, Killestein, J., Volkers, A.G., Tas, S.W., Boekel, L., Wolbink, G.J., Kooi, A.J. van der, Raaphorst, J., Lowenberg, M., Takkenberg, R.B., D'Haens, G.R.A.M., Spuls, P.I., Bekkenk, M.W., Musters, A.H., Post, N.F., Bosma, A.L., Hilhorst, M.L., Vegting, Y., Bemelman, F.J., Voskuyl, A.E., Broens, B., Sanchez, A.P., Els, C.A.C.M. van, Wit, J. de, Rutgers, A., Leeuw, K. de, Horvath, B., Verschuuren, J.J.G.M., Ruiter, A.M., Ouwerkerk, L. van, Woude, D. van der, Allaart, C.F., Teng, O.Y.K., Paassen, P. van, Busch, M.H., Jallah, P.B.P., Brusse, E., Doorn, P.A. van, Baars, A.E., Hijnen, D.J., Schreurs, C.R.G., Pol, W.L. van der, Goedee, H.S., Steenhuis, M., Keijzer, S., Keijser, J.B.D., Boogaard, A., Cristianawati, O., Brinke, A. ten, Verstegen, N.J.M., Zwinderman, K.A.H., Rispens, T., Ham, S.M. van, Kuijpers, T.W., Eftimov, F., T2B Immunity Against SARS Co
Publikováno v:
Annals of the Rheumatic Diseases, 81(12):222904, 1757-1766. BMJ Publishing Group
Annals of the rheumatic diseases, 81(12):222904, 1757-1766. BMJ Publishing Group
Annals of the Rheumatic Diseases, 81, 1757-1766. BMJ PUBLISHING GROUP
Annals of the Rheumatic Diseases, 81(12), 1757-1766. BMJ Publishing Group
Stalman, E W, Wieske, L, van Dam, K P J, Kummer, L Y, van Kempen, Z L E, Killestein, J, Volkers, A G, Tas, S W, Boekel, L, Wolbink, G J, van der Kooi, A J, Raaphorst, J, Löwenberg, M, Takkenberg, R B, D'Haens, G R A M, Spuls, P I, Bekkenk, M W, Musters, A H, Post, N F, Bosma, A L, Hilhorst, M L, Vegting, Y, Bemelman, F J, Voskuyl, A E, Broens, B, Parra Sanchez, A, van Els, C C A C M, Wit, J D, Rutgers, A, de Leeuw, K, Horváth, B, Verschuuren, J J G M, Ruiter, A M, van Ouwerkerk, L, van der Woude, D, Allaart, C F, Teng, O Y K, van Paassen, P, Busch, M H, Jallah, P B P, Brusse, E, van Doorn, P A, Baars, A E, Hijnen, D J, Schreurs, C R G, van der Pol, W L, Goedee, H S, Steenhuis, M, Keijzer, S, Keijser, J B D, Boogaard, A, Cristianawati, O, ten Brinke, A, Verstegen, N J M, Zwinderman, K A H, Rispens, T, van Ham, S M, Kuijpers, T W & Eftimov, F 2022, ' Breakthrough infections with the SARS-CoV-2 omicron (B.1.1.529) variant in patients with immune-mediated inflammatory diseases ', Annals of the Rheumatic Diseases, vol. 81, no. 12, 222904, pp. 1757-1766 . https://doi.org/10.1136/ard-2022-222904
Annals of the Rheumatic Diseases, 81(12). BMJ PUBLISHING GROUP
Annals of the rheumatic diseases, 81(12):222904, 1757-1766. BMJ Publishing Group
Annals of the Rheumatic Diseases, 81, 1757-1766. BMJ PUBLISHING GROUP
Annals of the Rheumatic Diseases, 81(12), 1757-1766. BMJ Publishing Group
Stalman, E W, Wieske, L, van Dam, K P J, Kummer, L Y, van Kempen, Z L E, Killestein, J, Volkers, A G, Tas, S W, Boekel, L, Wolbink, G J, van der Kooi, A J, Raaphorst, J, Löwenberg, M, Takkenberg, R B, D'Haens, G R A M, Spuls, P I, Bekkenk, M W, Musters, A H, Post, N F, Bosma, A L, Hilhorst, M L, Vegting, Y, Bemelman, F J, Voskuyl, A E, Broens, B, Parra Sanchez, A, van Els, C C A C M, Wit, J D, Rutgers, A, de Leeuw, K, Horváth, B, Verschuuren, J J G M, Ruiter, A M, van Ouwerkerk, L, van der Woude, D, Allaart, C F, Teng, O Y K, van Paassen, P, Busch, M H, Jallah, P B P, Brusse, E, van Doorn, P A, Baars, A E, Hijnen, D J, Schreurs, C R G, van der Pol, W L, Goedee, H S, Steenhuis, M, Keijzer, S, Keijser, J B D, Boogaard, A, Cristianawati, O, ten Brinke, A, Verstegen, N J M, Zwinderman, K A H, Rispens, T, van Ham, S M, Kuijpers, T W & Eftimov, F 2022, ' Breakthrough infections with the SARS-CoV-2 omicron (B.1.1.529) variant in patients with immune-mediated inflammatory diseases ', Annals of the Rheumatic Diseases, vol. 81, no. 12, 222904, pp. 1757-1766 . https://doi.org/10.1136/ard-2022-222904
Annals of the Rheumatic Diseases, 81(12). BMJ PUBLISHING GROUP
ObjectivesTo compare the cumulative incidence and disease severity of reported SARS-CoV-2 omicron breakthrough infections between patients with immune-mediated inflammatory diseases (IMID) on immunosuppressants and controls, and to investigate determ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19dc8c343aa3a7c58690faa029528df1
https://pure.eur.nl/en/publications/95be4c3a-8d51-4bec-a116-f9d40c9a985a
https://pure.eur.nl/en/publications/95be4c3a-8d51-4bec-a116-f9d40c9a985a
Autor:
Peters S., Vlaanderen J., Portengen L., Vermeulen R., Visser A. E., Veldink J. H., Van Den Berg L. H., D'Ovidio F., Chio A., Beghi E., Pupillo E., Logroscino G., Hardiman O., Van Der Kooi A. J., Raaphorst J., Calvo A., Moglia C., Casale F., Fuda G., Canosa A., Manera U., Bombaci A., Grassano M., Vasta R., Salamone P., Marrali G., Iazzolino B., Mazzini L., Rooney J., Heverin M., Vajda A., Comi G., Riva N., Lunetta C., Gerardi F., Filosto M., Cotelli M. S., Rinaldi F., Chiveri L., Guaita M. C., Perrone P., Mauro C., Diamanti L., Ferrarese C., Tremolizzo L., Delodovici M. L., Bono G., Tortelli R., Zecca C.
Publikováno v:
Journal of Neurology, Neurosurgery and Psychiatry, 91(1), 33-39. BMJ Publishing Group
Journal of Neurology, Neurosurgery and Psychiatry, 91(1), 33. BMJ Publishing Group
Journal of Neurology, Neurosurgery and Psychiatry, 91(1), 33. BMJ Publishing Group
BackgroundWe investigated the association between cigarette smoking and risk of amyotrophic lateral sclerosis (ALS) in a pooled analysis of population-based case–control studies and explored the independent effects of intensity, duration and time-s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::baeb897885d62f720e04fdfc0b4de33c
http://hdl.handle.net/10281/271131
http://hdl.handle.net/10281/271131
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.